Report Detail
Global Azelamide MEA Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032
- RnM4731711 |
- 13 August, 2026 |
- Global |
- 101 Pages |
- GIR |
- Chemical & Material
According to our (Global Info Research) latest study, the global Azelamide MEA market size was valued at US$ 22.66 million in 2025 and is forecast to a readjusted size of US$ 34.68 million by 2032 with a CAGR of 6.2% during review period.
In 2025, global sales volume of Azelamide MEA is estimated at approximately 143 tons, with the mainstream ex-works price at around USD 154/kg. Gross margin of major manufacturers is approximately 45%–65%.
Azelamide MEA, CAS No. 242132-61-2, is an azelaic acid derivative cosmetic active ingredient, in which MEA refers to the monoethanolamine structure. Compared with traditional azelaic acid, Azelamide MEA offers better water solubility, formulation mildness, and ease of use, making it more suitable for functional skincare and personal care formulations. It is not a conventional acid exfoliating ingredient, but is positioned more as a mild active ingredient for oil control, acne care, brightening, and skin conditioning.
The product is usually supplied in both powder and liquid forms. The powder form is mostly used as a high-purity cosmetic active ingredient, while the liquid form is generally a pre-dissolved or compound ingredient designed for easier formulation addition. It can be used in serum, lotion, cream, gel, scalp treatment, and localized care product. Its core value lies in retaining the advantages of the azelaic acid system in sebum regulation, acne-prone skin care, complexion improvement, and soothing care, while improving formulation compatibility through amidation and the MEA structure, thereby reducing the limitations of traditional azelaic acid in solubility, irritation, and formulation stability.
From a market positioning perspective, Azelamide MEA is a niche but fast-growing high-value cosmetic active ingredient, mainly serving segmented applications such as facial care, scalp care, and body care. As functional skincare continues to shift from single, strongly irritating acid ingredients toward milder, compound, and long-term-use solutions, Azelamide MEA is expected to gain further application potential in brand formulations.
This report is a detailed and comprehensive analysis for global Azelamide MEA market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Azelamide MEA market size and forecasts, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/kg), 2021-2032
Global Azelamide MEA market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/kg), 2021-2032
Global Azelamide MEA market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/kg), 2021-2032
Global Azelamide MEA market shares of main players, shipments in revenue ($ Million), sales quantity (Tons), and ASP (US$/kg), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Azelamide MEA
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Azelamide MEA market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Vevy Europe S.p.A., Beri Pharma, UCUS Biotech, Suzhou Health Chemicals, Suzhou Sunland Pharmatech, ZLEY Guangzhou Biological Research, Puripharm, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Azelamide MEA market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
High Purity (≥98.5%)
Regular Purity (95%–<98.5%)
Market segment by Form
Powder
Liquid
Market segment by Application
Facial Care
Scalp Care
Body Care
Other
Major players covered
Vevy Europe S.p.A.
Beri Pharma
UCUS Biotech
Suzhou Health Chemicals
Suzhou Sunland Pharmatech
ZLEY Guangzhou Biological Research
Puripharm
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Azelamide MEA product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Azelamide MEA, with price, sales quantity, revenue, and global market share of Azelamide MEA from 2021 to 2026.
Chapter 3, the Azelamide MEA competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Azelamide MEA breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Azelamide MEA market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Azelamide MEA.
Chapter 14 and 15, to describe Azelamide MEA sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
- 1.1 Product Overview and Scope
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Market Analysis by Type
- 1.3.1 Overview: Global Azelamide MEA Consumption Value by Type: 2021 Versus 2025 Versus 2032
- 1.3.2 High Purity (≥98.5%)
- 1.3.3 Regular Purity (95%–<98.5%)
- 1.4 Market Analysis by Form
- 1.4.1 Overview: Global Azelamide MEA Consumption Value by Form: 2021 Versus 2025 Versus 2032
- 1.4.2 Powder
- 1.4.3 Liquid
- 1.5 Market Analysis by Application
- 1.5.1 Overview: Global Azelamide MEA Consumption Value by Application: 2021 Versus 2025 Versus 2032
- 1.5.2 Facial Care
- 1.5.3 Scalp Care
- 1.5.4 Body Care
- 1.5.5 Other
- 1.6 Global Azelamide MEA Market Size & Forecast
- 1.6.1 Global Azelamide MEA Consumption Value (2021 & 2025 & 2032)
- 1.6.2 Global Azelamide MEA Sales Quantity (2021-2032)
- 1.6.3 Global Azelamide MEA Average Price (2021-2032)
2 Manufacturers Profiles
- 2.1 Vevy Europe S.p.A.
- 2.1.1 Vevy Europe S.p.A. Details
- 2.1.2 Vevy Europe S.p.A. Major Business
- 2.1.3 Vevy Europe S.p.A. Azelamide MEA Product and Services
- 2.1.4 Vevy Europe S.p.A. Azelamide MEA Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.1.5 Vevy Europe S.p.A. Recent Developments/Updates
- 2.2 Beri Pharma
- 2.2.1 Beri Pharma Details
- 2.2.2 Beri Pharma Major Business
- 2.2.3 Beri Pharma Azelamide MEA Product and Services
- 2.2.4 Beri Pharma Azelamide MEA Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.2.5 Beri Pharma Recent Developments/Updates
- 2.3 UCUS Biotech
- 2.3.1 UCUS Biotech Details
- 2.3.2 UCUS Biotech Major Business
- 2.3.3 UCUS Biotech Azelamide MEA Product and Services
- 2.3.4 UCUS Biotech Azelamide MEA Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.3.5 UCUS Biotech Recent Developments/Updates
- 2.4 Suzhou Health Chemicals
- 2.4.1 Suzhou Health Chemicals Details
- 2.4.2 Suzhou Health Chemicals Major Business
- 2.4.3 Suzhou Health Chemicals Azelamide MEA Product and Services
- 2.4.4 Suzhou Health Chemicals Azelamide MEA Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.4.5 Suzhou Health Chemicals Recent Developments/Updates
- 2.5 Suzhou Sunland Pharmatech
- 2.5.1 Suzhou Sunland Pharmatech Details
- 2.5.2 Suzhou Sunland Pharmatech Major Business
- 2.5.3 Suzhou Sunland Pharmatech Azelamide MEA Product and Services
- 2.5.4 Suzhou Sunland Pharmatech Azelamide MEA Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.5.5 Suzhou Sunland Pharmatech Recent Developments/Updates
- 2.6 ZLEY Guangzhou Biological Research
- 2.6.1 ZLEY Guangzhou Biological Research Details
- 2.6.2 ZLEY Guangzhou Biological Research Major Business
- 2.6.3 ZLEY Guangzhou Biological Research Azelamide MEA Product and Services
- 2.6.4 ZLEY Guangzhou Biological Research Azelamide MEA Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.6.5 ZLEY Guangzhou Biological Research Recent Developments/Updates
- 2.7 Puripharm
- 2.7.1 Puripharm Details
- 2.7.2 Puripharm Major Business
- 2.7.3 Puripharm Azelamide MEA Product and Services
- 2.7.4 Puripharm Azelamide MEA Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.7.5 Puripharm Recent Developments/Updates
3 Competitive Environment: Azelamide MEA by Manufacturer
- 3.1 Global Azelamide MEA Sales Quantity by Manufacturer (2021-2026)
- 3.2 Global Azelamide MEA Revenue by Manufacturer (2021-2026)
- 3.3 Global Azelamide MEA Average Price by Manufacturer (2021-2026)
- 3.4 Market Share Analysis (2025)
- 3.4.1 Producer Shipments of Azelamide MEA by Manufacturer Revenue ($MM) and Market Share (%): 2025
- 3.4.2 Top 3 Azelamide MEA Manufacturer Market Share in 2025
- 3.4.3 Top 6 Azelamide MEA Manufacturer Market Share in 2025
- 3.5 Azelamide MEA Market: Overall Company Footprint Analysis
- 3.5.1 Azelamide MEA Market: Region Footprint
- 3.5.2 Azelamide MEA Market: Company Product Type Footprint
- 3.5.3 Azelamide MEA Market: Company Product Application Footprint
- 3.6 New Market Entrants and Barriers to Market Entry
- 3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
- 4.1 Global Azelamide MEA Market Size by Region
- 4.1.1 Global Azelamide MEA Sales Quantity by Region (2021-2032)
- 4.1.2 Global Azelamide MEA Consumption Value by Region (2021-2032)
- 4.1.3 Global Azelamide MEA Average Price by Region (2021-2032)
- 4.2 North America Azelamide MEA Consumption Value (2021-2032)
- 4.3 Europe Azelamide MEA Consumption Value (2021-2032)
- 4.4 Asia-Pacific Azelamide MEA Consumption Value (2021-2032)
- 4.5 South America Azelamide MEA Consumption Value (2021-2032)
- 4.6 Middle East & Africa Azelamide MEA Consumption Value (2021-2032)
5 Market Segment by Type
- 5.1 Global Azelamide MEA Sales Quantity by Type (2021-2032)
- 5.2 Global Azelamide MEA Consumption Value by Type (2021-2032)
- 5.3 Global Azelamide MEA Average Price by Type (2021-2032)
6 Market Segment by Application
- 6.1 Global Azelamide MEA Sales Quantity by Application (2021-2032)
- 6.2 Global Azelamide MEA Consumption Value by Application (2021-2032)
- 6.3 Global Azelamide MEA Average Price by Application (2021-2032)
7 North America
- 7.1 North America Azelamide MEA Sales Quantity by Type (2021-2032)
- 7.2 North America Azelamide MEA Sales Quantity by Application (2021-2032)
- 7.3 North America Azelamide MEA Market Size by Country
- 7.3.1 North America Azelamide MEA Sales Quantity by Country (2021-2032)
- 7.3.2 North America Azelamide MEA Consumption Value by Country (2021-2032)
- 7.3.3 United States Market Size and Forecast (2021-2032)
- 7.3.4 Canada Market Size and Forecast (2021-2032)
- 7.3.5 Mexico Market Size and Forecast (2021-2032)
8 Europe
- 8.1 Europe Azelamide MEA Sales Quantity by Type (2021-2032)
- 8.2 Europe Azelamide MEA Sales Quantity by Application (2021-2032)
- 8.3 Europe Azelamide MEA Market Size by Country
- 8.3.1 Europe Azelamide MEA Sales Quantity by Country (2021-2032)
- 8.3.2 Europe Azelamide MEA Consumption Value by Country (2021-2032)
- 8.3.3 Germany Market Size and Forecast (2021-2032)
- 8.3.4 France Market Size and Forecast (2021-2032)
- 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
- 8.3.6 Russia Market Size and Forecast (2021-2032)
- 8.3.7 Italy Market Size and Forecast (2021-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Azelamide MEA Sales Quantity by Type (2021-2032)
- 9.2 Asia-Pacific Azelamide MEA Sales Quantity by Application (2021-2032)
- 9.3 Asia-Pacific Azelamide MEA Market Size by Region
- 9.3.1 Asia-Pacific Azelamide MEA Sales Quantity by Region (2021-2032)
- 9.3.2 Asia-Pacific Azelamide MEA Consumption Value by Region (2021-2032)
- 9.3.3 China Market Size and Forecast (2021-2032)
- 9.3.4 Japan Market Size and Forecast (2021-2032)
- 9.3.5 South Korea Market Size and Forecast (2021-2032)
- 9.3.6 India Market Size and Forecast (2021-2032)
- 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
- 9.3.8 Australia Market Size and Forecast (2021-2032)
10 South America
- 10.1 South America Azelamide MEA Sales Quantity by Type (2021-2032)
- 10.2 South America Azelamide MEA Sales Quantity by Application (2021-2032)
- 10.3 South America Azelamide MEA Market Size by Country
- 10.3.1 South America Azelamide MEA Sales Quantity by Country (2021-2032)
- 10.3.2 South America Azelamide MEA Consumption Value by Country (2021-2032)
- 10.3.3 Brazil Market Size and Forecast (2021-2032)
- 10.3.4 Argentina Market Size and Forecast (2021-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Azelamide MEA Sales Quantity by Type (2021-2032)
- 11.2 Middle East & Africa Azelamide MEA Sales Quantity by Application (2021-2032)
- 11.3 Middle East & Africa Azelamide MEA Market Size by Country
- 11.3.1 Middle East & Africa Azelamide MEA Sales Quantity by Country (2021-2032)
- 11.3.2 Middle East & Africa Azelamide MEA Consumption Value by Country (2021-2032)
- 11.3.3 Turkey Market Size and Forecast (2021-2032)
- 11.3.4 Egypt Market Size and Forecast (2021-2032)
- 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
- 11.3.6 South Africa Market Size and Forecast (2021-2032)
12 Market Dynamics
- 12.1 Azelamide MEA Market Drivers
- 12.2 Azelamide MEA Market Restraints
- 12.3 Azelamide MEA Trends Analysis
- 12.4 Porters Five Forces Analysis
- 12.4.1 Threat of New Entrants
- 12.4.2 Bargaining Power of Suppliers
- 12.4.3 Bargaining Power of Buyers
- 12.4.4 Threat of Substitutes
- 12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
- 13.1 Raw Material of Azelamide MEA and Key Manufacturers
- 13.2 Manufacturing Costs Percentage of Azelamide MEA
- 13.3 Azelamide MEA Production Process
- 13.4 Industry Value Chain Analysis
14 Shipments by Distribution Channel
- 14.1 Sales Channel
- 14.1.1 Direct to End-User
- 14.1.2 Distributors
- 14.2 Azelamide MEA Typical Distributors
- 14.3 Azelamide MEA Typical Customers
15 Research Findings and Conclusion
16 Appendix
- 16.1 Methodology
- 16.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on Azelamide MEA. Industry analysis & Market Report on Azelamide MEA is a syndicated market report, published as Global Azelamide MEA Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Azelamide MEA market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
